Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Med-Tek
AddedFeb 15, 2024
UpdatedJun 18, 2026
Med-Tek

Med-Tek

Pre-Seed

Med-Tek provides innovative healthcare tech solutions, improving efficiencies in patient care and data management with our proprietary CMAPpro device.

HQ
Miami, FL, US
Founded
2002
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to revolutionize healthcare technology, Med-Tek aims to enhance patient care and data management through innovative solutions. The company offers the CMAPpro device, which provides treating physicians with objective, clinically validated data on soft tissue pathologies and injuries. Med-Tek focuses on creating synergistic gains in efficiency and improving outcomes across the healthcare spectrum, positioning itself as a key player in the global healthcare economy.

Med-Tek has garnered attention from notable investors and industry leaders who recognize its potential to transform healthcare delivery. The company's key achievements include the successful deployment of its CMAPpro device in multiple healthcare facilities, leading to significant improvements in diagnostic accuracy and patient outcomes. Med-Tek's impact is evident in its ability to streamline healthcare processes and provide cutting-edge technological solutions that benefit both providers and patients.

Med-Tek - Similar Companies

MobileMedTek logo

MobileMedTek

Medtel.com logo

Medtel.com

medtel.com

Medtech Innovator logo

Medtech Innovator

MedTech Exchange logo

MedTech Exchange

MedicaMetrix logo

MedicaMetrix

medicametrix.com

Mednet logo

Mednet

Medtor logo

Medtor

medtorllc.com

Meditech logo

Meditech

meditech.com

Medicom Technologies logo

Medicom Technologies

medicom.us

Medpac Technologies logo

Medpac Technologies

MedTek eCoin logo

MedTek eCoin

Medifies logo

Medifies

medifies.com

Advanced Medical Device Technologies logo

Advanced Medical Device Technologies

advancedmdt.com

Medcurio logo

Medcurio

medcurio.com

Medical Engineering Innovations logo

Medical Engineering Innovations

mei-america.com

Med-Tek - Quick Facts

Who are Med-Tek's competitors?

Companies similar to Med-Tek include MobileMedTek, Medtel.com, Medtech Innovator and MedTech Exchange.

When was Med-Tek founded?

Med-Tek was founded in 2002.

Where is Med-Tek's headquarters located?

Med-Tek's headquarters is located in Miami, FL, US.

When was Med-Tek's last funding round?

Med-Tek's most recent funding round was for $550k (USD) in March 2015.

How much has Med-Tek raised to-date?

As of Mar 13, 2015, Med-Tek has raised a total of $16M (USD).

How many employees does Med-Tek have?

Med-Tek has 75 employees as of Feb 4, 2024.

Med-Tek - Classification

Ownership
  • Private
Technology
  • Analytics
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Healthcare
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software